title: Sacubitril-Valsartan for the Treatment of Heart Failure: Effectiveness and Value.
authors.affiliation: Institute for Clinical and Economic Review, Boston, Massachusetts.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Ollendorf
authors.affiliation: Center for Health Policy/Center for Primary Care and Outcomes Research, Department of Medicine, Stanford University, Palo Alto, California.
authors.forename: Alexander T
authors.initials: AT
authors.lastname: Sandhu
authors.affiliation: Institute for Clinical and Economic Review, Boston, Massachusetts.
authors.forename: Steven D
authors.initials: SD
authors.lastname: Pearson
mesh_terms: D000613:Aminobutyrates / Q000191:economics / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists / Q000191:economics / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D013777:Tetrazoles / Q000191:economics / Q000627:therapeutic use*; D000068756:Valsartan
chemical_list: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D000068756:Valsartan; C549068:sacubitril and valsartan sodium hydrate drug combination